- FTC, DOJ Seek Public Comment on Proposed Statement of Antitrust Enforcement Policy Regarding Accountable Care Organizations ( )
- FTC Denies North Carolina Dental Board's Motion to Dismiss Allegations That it Stifled Competition for Teeth-Whitening Services ( )
- FTC and Ohio Attorney General Challenge ProMedica's Acquisition of St. Luke's Hospital ( )
- FTC Testifies on Antitrust Enforcement in the Health Care Industry ( )
- FTC Challenges LabCorp's Acquisition of Rival Clinical Laboratory Testing Company ( )
- FTC Requires Universal Health Services to Sell 15 Psychiatric Facilities as a Condition of Acquiring Rival Psychiatric Solutions ( )
- FTC, HHS Office of Inspector General, and Centers for Medicare & Medicaid Services Announce Workshop on Issues Related to Accountable Care Organizations ( )
- FTC Staff Opinion: Yakima Valley Memorial Hospital's Proposed Rx Program Exempt From the Robinson-Patman Act ( )
- Court Orders Internet Marketers of Acai Berry Weight-Loss Pills and "Colon Cleansers" to Stop Deceptive Advertising and Unfair Billing Practices ( )
- FTC Staff Opinion: Community CarePartners, Inc.'s Proposed Discount Rx Program Exempt From the Robinson-Patman Act ( )
- Minnesota Health Care Provider Group Settles FTC Price Fixing Charges ( )
- FTC Chairman Addresses American Medical Association ( )
- FTC Files Amicus Brief in Support of Rehearing of Ciprofloxacin "Pay-for-Delay" Case; FTC Approves Final Rule to Inform Consumers About Deposit Institutions That Lack Federal Deposit Insurance ( )
- Statement by FTC Chairman Jon Leibowitz Regarding Todays Decision by the U.S. Court of Appeals for the Second Circuit in the Ciprofloxacin "Pay-for-Delay" Case ( )
- FTC Staff Opinion: University of Michigans Proposed Rx Program Exempt From Robinson-Patman Act ( )
- FTC Provides Comments to FCC on Protecting Children in Traditional and New Media Environments; FTC Approves Final Settlement Order Regarding The M Group, Inc., Doing Business As Bamboosa; FTC Approves Final Settlement Order Regarding Roaring Fork Valley ( )
- FTC Approves Final Settlement Orders Regarding Boulder Valley IPA and M. Catherine Higgins; Commission Submits Comments on Measuring the Performance of Electric Regional Transmission Organizations and on FERCs Method of Assessing Partial Acquisitions ( )
- Commission Approves Carilion Clinic's Application to Sell Center for Surgical Excellence to Fairlawn Surgery Center, LLC ( )
- Statement by FTC Chairman Jon Leibowitz Regarding Today’s District Court Decision Denying a Motion to Dismiss the Commission’s Pay-For-Delay Case Against Cephalon Inc. ( )
- FTC Approves Final Settlement Order Regarding Danaher Corporation and MDS, Inc. ( )
- Statement by FTC Chairman Jon Leibowitz Regarding Continuing Need for Legislation Banning Illegal Pay-for-Delay Drug Settlements ( )
- Statement of Federal Trade Commission Chairman Jon Leibowitz on Ending Pay-for-Delay Drug Settlements, Praises Inclusion in Presidents Health Care Proposal ( )
- FTC Warns Marketers of Children's Omega-3 Fatty Acid Supplements That Claims About Brain and Vision Benefits May Be Deceptive ( )
- FTC Settles Charges That Colorado Physicians Group Director Attempted to Evade Terms of 2008 Price-Fixing Order ( )
- Colorado Physicians Group Agrees to Stop Alleged Price-Fixing Tactics ( )
- Commission Approves FY 2011 Budget Request and GPRA Performance Plans for Submission to Congress; FTC Staff: Proposed Kentucky Regulations for Licensing Retail Clinics Raise Competitive Concerns; FTC Issues Annual Financial Acts Enforcement Report to ( )
- FTC Approves Final Consent Order in Case of Pfizer Inc. and Wyeth ( )
- FTC Order Preserves Competition in Market for Important Scientific Research Device, While Allowing Danaher to Proceed with Purchase of MDS Analytical Technologies ( )
- Commission Seeks Public Comments on Carilion Clinics Application to Divest Center for Surgical Excellence to Fairlawn Surgery Center, LLC; FTC Approves The Dow Chemical Companys Petition to Divest its Acrylic Acid and Latex Polymers Businesses to Arkema ( )
- Commission Announces Revised Filing Thresholds for Clayton Act Antitrust Reviews; Commission Retains Amplifier Rule; Final Consent Orders against Six Businesses That Claimed to Comply With an International Privacy Framework ( )